Connect to other sites within the UBM Medica Network
Want to maximize the benefits and reduce potential harms of cervical cancer screening? Try these 4 strategies.
Back to Basics: The Well-Woman Visit
Don’t let time constraints and large patient loads prevent you from providing a thorough well-woman visit. Are you covering all the bases?
FDA Panel: HPV Test Can Replace Pap for Cervical Cancer Screening
An FDA panel has recommended that a DNA test that screens for HPV in women can replace the standard Pap smear as a first-line primary cervical cancer screening test.
Evidence Mounts for Effectiveness of National HPV Vaccine Program
Three doses of the quadrivalent HPV vaccine was more effective in preventing high-grade cervical abnormalities than other types and more effective in younger women.
HPV Vaccine Achieves Population-Level Reduction of Cervical Cancer Lesions
In Denmark, researchers found that the risk of atypia, atypia+, and cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) were significantly reduced among women who received the vaccine.
HPV Vaccine: How Many Doses Are Really Needed?
Two doses of quadrivalent human papillomavirus (HPV) vaccine protects against genital warts nearly as well as the standard 3-dose schedule, according to new study findings.
Vaccine Treatments Trigger Cervical Lesions to Disappear
New research, led by Connie Trimble, MD, shows that vaccine treatments for women with high-grade cervical dysplasia can trigger an immune response that may induce some lesions to resolve.
HPV Vaccine Not Linked to Riskier Sexual Behaviors
The sexual behaviors and beliefs about HPV infection were unchanged among a group of teens and young women who were vaccinated against the virus, research shows.